Pharmaceuticals & Biotechnology (4570)

20,170.26
   
  • 52 Week High: 24,649.93
  • 52 Week Low: 18,687.04

Latest ShareCast News

Morgan Stanley upgrades Haleon on sector leading exposure to defensive product categories

By Alexander Bueso

Date: Friday 09 May 2025

(Sharecast News) - Analysts at Morgan Stanley upgraded their recommendation for shares of consumer healthcare outfit Haleon.

Pharmaceuticals & Biotechnology Regulatory News

Alliance Pharma 09-May-2025 17:30 RNS
Publication of Circular 09-May-2025 16:38 RNS
Amendment to Result of AGM 09-May-2025 16:37 RNS
Form 8.3 - Alliance Pharma plc 09-May-2025 15:30 RNS
Form 8.3 - Alliance Pharma plc 09-May-2025 15:25 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 20,170.26
Closing Price Change 223.59
% Change 1.12 %
09-May-25 Close 20,170.26

Top Risers

Price Change
SVNS 0.17p +13.8%
FARN 230.00p +8.2%
IMM 3.13p +5.0%
ANP 450.00p +4.7%
BMK 22.00p +4.3%
HELD 0.99p +4.2%
NFX 0.13p +4.0%
OXB 296.50p +3.7%
HCM 228.00p +3.2%
N4P 0.53p +2.9%

Top Fallers

Price Change
PRM 2.84p -8.1%
IXI 9.00p -7.2%
STX 2.40p -5.9%
POLB 2.80p -5.1%
OPTI 18.50p -3.9%
SAR 17.50p -2.8%
EAH 62.50p -2.3%
AVCT 32.75p -2.2%
ONT 128.50p -1.8%
INDV 828.00p -1.6%

Top of Page